Trends in Treatment-Related Deaths (TRDs) in childhood cancer and leukemia over time: A follow-up of patients included in the Childhood Cancer Registry of the Rhône-Alpes Region in France (ARCERRA)

Pediatric Blood and Cancer

Volumn 50, Issue 6, 2008, Pages 1213-1220

  Freycon, Fernand ^a,f   Trombert Paviot, Béatrice ^b   Casagranda, Léonie ^b   Bertrand, Yves ^c   Plantaz, Dominique ^d   Marec Bérard, Perrine ^e  

^a Childhood Cancer Registry of the Rhône Alpes Region   (France)

^b UNIVERSITÉ JEAN MONNET   (France)

^c HÔPITAL DEBROUSSE   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e CENTRE LÉON BÉRARD   (France)

^f ARCERRA   (France)

Author keywords

Cancer registry; Childhood cancer; Childhood leukemia; Pediatric oncology; Transplantation related death; Treatment related death

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ALLOGRAFT; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; COHORT STUDIES; FEMALE; FRANCE; GUIDELINE ADHERENCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REGISTRIES;

EID: 42349114112     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21506     Document Type: Article

References (27)

1. Magnani C, Pastore G, Coebergh JW, et al. Trends in survival after childhood cancer in Europe, 1978-1997: Report from the Automated Childhood Cancer Information System project (ACCIS). Eur J Cancer 2006;42:1981-2005.
2. Berger C, Trombert-Paviot B, Mitton N, et al. Childhood cancer incidence and survival rates in the Rhône-Alpes regional paediatric registry 1987-1999. Arch Pediatr 2006;13:121-129. (Article in French).
3. Goubin A, Auclerc MF, Auvrignon A, et al. Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000). Eur J Cancer 2006;42:534-541.
4. Spix C, Pastore G, Sankila R, et al. Neuroblastoma incidence and survival in European children (1978-1997): Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42:2081-2091.
5. Stiller CA, Bielak SS, Jundt G, et al. Bone tumours in European children and adolescents, 1978-1997: Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42:2124-2135.
6. Peris-Bonet R, Martinez-Garcia C, Lacour B, et al. Childhood central nervous system tumours - Incidence and survival in Europe (1978-1997): Report from Automated Childhood Cancer Information System project. Eur J Cancer 2006;42:2064-2080.
7. Riley LC, Hann IM, Wheatley K, et al. Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council myeloid leukaemia trial (MRC AML 10). The MRC Childhood Leukaemia Working Party. Br J Haematol 1999;106:436-444.
8. Hargrave DR, Hann II, Richards SM, et al. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). Br J Haematol 2001;112:293-299.
9. Slats AM, Egeler RM, van der Does-van den Berg A, et al. Causes of death - Other than progressive leukaemia - In childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): The Dutch Childhood Oncology Group experience. Leukemia 2005;19:537-544.
10. Christensen MS, Heyman M, Mottonen M, et al. Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001. Br J Haematol 2005;131:50-58.
11. Yanchar NL, Bass J. Poor outcome of gastrointestinal perforation associated with childhood abdominal non-Hodgkin's lymphoma. J Pediatr Surg 1999;34:1169-1174.
12. Shields LB, Hunsaker DM, Hunsaker JC III. Iatrogeneic catheter-related cardiac tamponade: A case report of fatal hydropericardium following subcutaneous implantation of a chemotherapeutic injection port. J Forensic Sci 2003;48:414-418.
13. Hudson MM, Jones D, Boyett J, et al. Late mortality of long-term survivors of childhood cancer. J Clin Oncol 1997;15:2205-2213.
14. Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. J Clin Oncol 2001;19:3161-3172.
15. Cardous-Ubbink MC, Heinen RC, Langeveld NE, et al. Long-term cause-specific mortality among five-year survivors of childhood cancer. Pediatr Blood Cancer 2004;42:563-573.
16. Steliarova-Foucher E, Stiller C, Lacour B, et al. International classification of childhood cancer, third edition. Cancer 2005;103:1457-1467.
17. Souillet G, Rey S, Bertrand Y. Outcome of unrelated bone marrow donor searches in 174 children resulting in 45 patients transplanted in the HLA-matched and -mismatched situation. Bone Marrow Transplant 2000;26:31-43.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
19. Schrappe M, Reiter A, Zimmermann M, et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia 2000;14:2205-2222.
20. Kardos G, Zwaan CM, Kaspers GJ, et al. Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials. Leukemia 2005;19:2063-2071.
21. Creutzig U, Zimmermann M, Reinhardt D, et al. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: Analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004;22:4384-4393.
22. Moussalem M, Esperou Bourdeau H, Devergie A, et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: Factors predictive of survival, relapse and graft-versus-host disease. Bone Marrow Transplant 1995;15:943-947.
23. Bunin N, Carsten M, Wall D, et al. National Marrow Donor Program Working Group. Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 2002;99:3151-3157.
24. Borgmann A, von Stackelberg A, Hartmann R, et al. Berlin-Frankfurt- Munster Relapse Study Group. Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: A matched-pair analysis. Blood 2003;101:3835-3839.
25. Schrauder A, Reiter A, Gadner H, et al. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: Results from ALL-BFM 90 and 95. J Clin Oncol 2006;24:5742-5749.
26. Miano M, Labopin M, Hartmann O, et al. Paediatric Diseases Working Party of the European Group for Blood and Marrow Transplantation. Haematopoietic stem cell transplantation trends in children over the last three decades: A survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2007;39:89-99.
27. Ferry C, Gemayel G, Rocha V, et al. Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transplant 2007;40:219-224.